Mon, December 5, 2011
Sun, December 4, 2011
Fri, December 2, 2011
Thu, December 1, 2011
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
Mon, November 28, 2011
Sun, November 27, 2011
Fri, November 25, 2011
Thu, November 24, 2011
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
00 a.m. EST
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
BD Board Increases Dividend
Mon, November 21, 2011

Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. nt-at-the-oppenheimer-healthcare-conference.html
Published in Health and Fitness on Tuesday, November 29th 2011 at 2:42 GMT by Market Wire   Print publication without navigation


November 29, 2011 05:30 ET

Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Nov 29, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: [ THLD ]) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 2011 Oppenheimer 22nd Annual Healthcare Conference in New York City on Tuesday, December 13, 2011 at 9:55AM EST.

A live webcast of the presentation will be available under the Webcast section of the Company's Website at [ www.thresholdpharm.com ]

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website ([ www.thresholdpharm.com ]).



Publication Contributing Sources